Our comparative overview on RAS mutations in SGC confirms the finding of frequent HRAS mutations in EMC, however, compared to previous studies, HRAS mutation frequency in EMC was found to be much higher than estimated before and appears to reach 80% (4/5) [16, 32]. Here, HRAS is linked to extraskeletal myxoid chondrosarcoma.